HRT Financial’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.82M	Buy	131,241 +7,011	+6%	+$112K	0.01%	1676
2025 Q4	$2.02M	Buy	+124,230	New	+$2.03M	0.01%	1301
2025 Q1	–	Sell	-98,357	Closed	-$589K	–	2456
2024 Q4	$589K	Buy	98,357 +53,388	+119%	+$294K	﹤0.01%	1359
2024 Q3	$230K	Buy	+44,969	New	+$196K	﹤0.01%	1913
2023 Q3	–	Sell	-16,145	Closed	-$108K	–	2328
2023 Q2	$108K	Sell	16,145 -89,783	-85%	-$668K	﹤0.01%	1957
2023 Q1	$935K	Sell	105,928 -21,422	-17%	-$189K	0.01%	990
2022 Q4	$972K	Sell	127,350 -64,518	-34%	-$502K	0.01%	980
2022 Q3	$1.37M	Sell	191,868 -20,615	-10%	-$194K	0.02%	757
2022 Q2	$1.72M	Buy	212,483 +4,755	+2%	+$41.8K	0.02%	636
2022 Q1	$2.88M	Buy	+207,728	New	+$3.27M	0.02%	471
2021 Q2	–	Sell	-67,955	Closed	-$2.73M	–	2774
2021 Q1	$2.73M	Buy	+67,955	New	+$3.68M	0.03%	468